Navy Cracking Down on Steroid Use
The U.S. Navy is stepping up efforts to clamp down on steroid use by agency personnel, recent contracting documents show. The Naval Logistics Medical Command, through its Ft. Detrick, Md.-based Bureau of Medicine and Surgery, is assessing the availability of qualified labs capable of conducting about 400 steroid-specific urine-specimen analyses annually over the next five years. According to a sources-sought notice dated Dec. 12 and located via a routine search of the FedBizOpps database, the endeavor aims to detect the use of performance-enhancing drugs listed in the Anabolic Steroid Act of 2004, such as 19-nor-androsterone, Boldenone, Nandrolone, Stanozolol, Methandienone, Drostanonlone, Trenbolone, Methenolone, as well as other compounds. Though unconnected to the recent spate of high-profile cases in the media, the stepped-up testing coincides with the release of a Major League Baseball report revealing pervasive steroid use among professional ball players (see Steroid Report Names Star Players; Washington Post, 12/14/2007; free registration required).

